The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and [...]

scientific article

The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and [...] is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1021569981
P356DOI10.1186/2046-4053-3-89
P932PMC publication ID4139136
P698PubMed publication ID25128005
P5875ResearchGate publication ID264830711

P50authorChristian GluudQ26265142
Pia EgerupQ85229616
Jane LindschouQ89435998
Ole Bjarne ChristiansenQ95279412
P2860cites workIndustry sponsorship and research outcomeQ24202591
Immunotherapy for recurrent miscarriageQ24246153
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulantQ24247000
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysisQ24289436
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyQ24653790
Bias in meta-analysis detected by a simple, graphical testQ24685585
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analysesQ29619185
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methodsQ31108600
Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analysesQ33372680
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?Q33405903
Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.Q33494533
Estimating required information size by quantifying diversity in random-effects model meta-analyses.Q33521365
Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trialQ34071163
Bias in clinical intervention research.Q36380552
Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.Q36682273
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analysesQ37138228
A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriageQ37828263
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studiesQ38044510
Reproductive immunologyQ38051814
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?Q43707230
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsQ47192223
Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patiQ47313388
A study of HLA-DR and -DQ alleles in 588 patients and 562 controls confirms that HLA-DRB1*03 is associated with recurrent miscarriageQ47799523
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cellsQ48021167
Recurrent miscarriageQ56503650
Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortionQ60686838
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortionQ60686924
Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal LossQ60700021
A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriageQ61836166
Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG GroupQ61837913
Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriageQ61840976
Antinuclear antibodies in sera of patients with recurrent pregnancy wastageQ68602665
Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulinQ70915469
Intravenous immunoglobulin for treatment of recurrent pregnancy lossQ71016942
Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian studyQ74069520
Prevention of Unexplained Recurrent Spontaneous Abortion Using Intravenous Immunoglobulin: A Prospective, Randomized, Double‐Blinded, Placebo‐Controlled TrialQ74322522
Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled studyQ77379280
P921main subjectmeta-analysisQ815382
immunotherapyQ1427096
miscarriageQ28693
placeboQ269829
P304page(s)89
P577publication date2014-08-15
P13046publication type of scholarly worksystematic reviewQ1504425
P1433published inSystematic ReviewsQ18216009
P1476titleThe effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials
P478volume3

Reverse relations

Q26777807The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient Datacites workP2860

Search more.